Prostate cancer trials recruiting in District of Columbia

All Prostate cancer trials nationally

Cities in District of Columbia

Recruiting trials in District of Columbia

• A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
  NCT06925737 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · District of Columbia: Washington D.C.
• A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)
  NCT06863272 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · District of Columbia: Washington D.C.
• A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
  NCT06136650 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · District of Columbia: Washington D.C.
• A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
  NCT07164443 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · District of Columbia: Washington D.C.
• A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer
  NCT06764485 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · District of Columbia: Washington D.C.
• Assessing the Feasibility of Web-based Insomnia Treatment Among Prostate Cancer Survivors
  NCT07128927 · Phase: Not applicable (e.g. observational or device study) · Ages: 21 Years and older · Sex: Male · District of Columbia: Washington D.C.
• Cancer Experience Registry (CER) for Cancer Patients and Caregivers
  NCT02333604 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · District of Columbia: Washington D.C.
• Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
  NCT04038502 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · District of Columbia: Washington D.C.
• Castrate Resistant Prostate Cancer Enhertu Therapy
  NCT06610825 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · District of Columbia: Washington D.C.
• Clinical Trial of Approaches to Prostate Cancer Surgery
  NCT05155501 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years to 80 Years · Sex: Male · District of Columbia: Washington D.C.
• Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
  NCT05334069 · Phase: Not specified · Ages: 40 Years to 75 Years · Sex: All (male and female) · District of Columbia: Washington D.C.
• Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
  NCT06592924 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · District of Columbia: Washington D.C.
• Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
  NCT05983432 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · District of Columbia: Washington D.C.
• Evaluating Safety and Efficacy of Prostate-sparing Radical Cystectomy
  NCT05792722 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Male · District of Columbia: Washington D.C.
• FOG-001 in Locally Advanced or Metastatic Solid Tumors
  NCT05919264 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · District of Columbia: Washington D.C.
• Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
  NCT05803941 · Phase: Phase 4 · Ages: 18 Years to 100 Years · Sex: Male · District of Columbia: Washington D.C.
• MRI-based Focal Intraprostatic Simultaneous Integrated Boost (SIB) Intensification With De-escalated Adaptive-risk SBRT for Patients With Low to Intermediate Risk Prostate Cancer
  NCT07644598 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · District of Columbia: Washington D.C.
• Neoadjuvant Lu-177-PSMA-617 in Patients With High Risk Localized Prostate Cancer Undergoing Radical Prostatectomy
  NCT06798558 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · District of Columbia: Washington D.C.
• Polygenic Risk Stratification Combined With mpMRI to Identify Clinically Relevant Prostate Cancer
  NCT06398639 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years to 69 Years · Sex: Male · District of Columbia: Washington D.C.
• Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
  NCT03678025 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · District of Columbia: Washington D.C.
• TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers
  NCT04485013 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · District of Columbia: Washington D.C.
• Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
  NCT05946213 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · District of Columbia: Washington D.C.
• Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
  NCT06931340 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · District of Columbia: Washington D.C.
• Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
  NCT03866382 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · District of Columbia: Washington D.C.
• Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
  NCT04423211 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · District of Columbia: Washington D.C.
• Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
  NCT04787744 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: Male · District of Columbia: Washington D.C.